Tuesday could be the most important quarterly report of Pfizer CEO Albert Bourla’s career.
When the drugmaker releases third-quarter results around 7 a.m., the world …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Hope your weekend
TMB-001 is intended for the treatment of congenital ichthyosis, a rare skin condition. Credit: Kwangmoozaa / Shutterstock.com. Leo Pharma has entered an agreement for the acquisition of